Immunology News
🌏 NMPANMPA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–6 of 6 articles
UCB Acquires Candid Therapeutics for $2.2 Billion, Expanding T-Cell Engager Platform for Autoimmune Diseases
Kodiak Sciences KSI-101 Clinical Data to Be Presented at Scientific Conferences for Macular Edema Treatment
Vivacta Bio Raises $50M+ Series A Funding for GT801 CAR-T Gene Therapy Development
Samsung Bioepis Begins Phase 1 Trial for Novel ADC SBE303, Expands Sandoz Biosimilar Partnership
Biogen Acquires Felzartamab Rights from TJ Biopharma for Greater China Market
Zai Lab's ZL-1503 Bispecific Antibody Shows Promise for Rapid Itch Relief in Atopic Diseases